# Magnesium Trisilicate **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/magnesium-trisilicate **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-04-04 **Evidence Score:** 2 / 10 **Category:** Mineral **Also Known As:** Mg₂Si₃O₈, Magnesium silicate trihydrate, Trisilicic acid magnesium salt, Magnesium metasilicate, MSG trisilicate, Synthetic magnesium trisilicate, Pharmaceutical grade magnesium trisilicate ## Overview Magnesium trisilicate is an inorganic salt compound (Mg2Si3O8·nH2O) used primarily as an antacid and gastrointestinal adsorbent. It neutralizes gastric hydrochloric acid through a slow-reacting chemical buffering mechanism, producing magnesium chloride, silicon dioxide, and water as byproducts. ## Health Benefits • Acid neutralization for peptic ulcer treatment - approved antacid though with slow reaction time deemed ineffective for OTC use • Theoretical acid-neutralizing capacity of 12-17 mEq per gram when suspended in water (USP data) • Adsorption properties for removing fatty acids and impurities due to open crystal structure • Limited clinical evidence available - no RCTs or human trials documented • Industrial applications include odor absorption and decolorizing agent properties ## Mechanism of Action Magnesium trisilicate reacts with hydrochloric acid in the stomach to form magnesium chloride and colloidal silicon dioxide (SiO2), buffering gastric pH through ion exchange rather than rapid neutralization. The colloidal silica gel produced in situ exhibits significant adsorptive capacity, binding fatty acids, bile salts, and other polar impurities via surface hydroxyl groups. Its theoretical acid-neutralizing capacity of 12–17 mEq per gram (per USP standards when suspended in water) is comparatively high, but the slow reaction kinetics limit its clinical utility as a standalone acute antacid. ## Clinical Summary Magnesium trisilicate has been evaluated primarily in older peptic ulcer disease literature, with most data predating modern placebo-controlled trials; robust randomized controlled trial evidence is limited. Combination antacid formulations including magnesium trisilicate demonstrated symptomatic acid relief in small clinical studies, though the FDA has classified it as not generally recognized as safe and effective (GRASE) for OTC antacid use due to insufficient evidence of rapid efficacy. Animal studies raised concerns about chronic high-dose use leading to silica-containing urinary tract stones (silica urolithiasis), which has tempered enthusiasm for its widespread use. Overall, the clinical evidence base is weak by modern standards, and it has largely been superseded by proton pump inhibitors and H2 receptor antagonists. ## Nutritional Profile Magnesium Trisilicate (Mg2Si3O8·nH2O) is an inorganic mineral compound, not a nutritional ingredient in the traditional sense — it provides no calories, protein, fat, or fiber. Its primary bioactive components are magnesium (Mg²⁺) and silicate (SiO₄⁴⁻) ions released upon contact with gastric acid. Each gram theoretically yields approximately 12–17 mEq of acid-neutralizing capacity (USP standard). Magnesium content is approximately 29% by molecular weight, though bioavailability of this magnesium is low and variable due to the slow dissolution kinetics of the silicate matrix. The silica gel byproduct formed during acid neutralization contributes adsorptive capacity for bile acids and fatty acids but is not absorbed. Systemic magnesium absorption from this compound is minimal under normal gastrointestinal conditions, distinguishing it from bioavailable magnesium salts like magnesium glycinate or citrate. Silicon as orthosilicic acid may be partially absorbed (~1–2%) but clinical significance is not established. ## Dosage & Preparation No clinically studied dosage ranges are available from human trials. USP-grade magnesium trisilicate (≥20% MgO, ≥45% SiO₂) is administered as a powder suspended in water, with 1 gram theoretically neutralizing 12-17 mEq of acid. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Chronic high-dose ingestion of magnesium trisilicate has been associated with silica nephrolithiasis (silica kidney stones) in animal models, and prolonged use in humans is discouraged for this reason. The magnesium component can cause osmotic diarrhea and, in patients with renal insufficiency, hypermagnesemia due to impaired magnesium excretion. Magnesium trisilicate can chelate and reduce the oral absorption of tetracycline antibiotics, fluoroquinolones, iron supplements, and certain antifungal drugs such as ketoconazole, and a minimum 2-hour separation is recommended. Its safety in pregnancy has not been well established; the silica component raises theoretical concerns, and use during pregnancy should be avoided without explicit medical guidance. ## Scientific Research No specific human clinical trials, RCTs, or meta-analyses for magnesium trisilicate were found in the available research. The compound is noted as an approved antacid for peptic ulcer treatment, but clinical evidence for its effectiveness is limited to theoretical acid-neutralizing calculations rather than controlled studies. ## Historical & Cultural Context No historical or traditional medicinal uses in systems like Ayurveda or TCM are documented. Modern applications include its use as an antacid for peptic ulcers, industrial odor absorbent, and food additive for absorbing frying oil impurities. ## Synergistic Combinations Magnesium Trisilicate pairs functionally with Aluminum Hydroxide, as the combination buffers gastric pH more effectively and sustainably — aluminum hydroxide provides faster onset acid neutralization while magnesium trisilicate's slower release extends duration, also counterbalancing aluminum's constipating effects with magnesium's mild laxative tendency. Sodium Alginate complements it in reflux management by forming a viscous raft atop gastric contents, preventing acid regurgitation while magnesium trisilicate addresses the underlying acid load — this combination is used in commercial formulations like Gaviscon. Licorice Root extract (deglycyrrhizinated, DGL) synergizes via a complementary mechanistic pathway, stimulating mucin production and [prostaglandin](/ingredients/condition/inflammation)-mediated mucosal protection while magnesium trisilicate handles luminal acid neutralization, covering both cytoprotective and chemical buffering pathways for peptic ulcer management. ## Frequently Asked Questions ### Why is magnesium trisilicate not approved for OTC antacid use in the US? The FDA determined that magnesium trisilicate does not meet GRASE (generally recognized as safe and effective) criteria for OTC antacid use primarily due to its slow acid-neutralization kinetics, which make it ineffective for prompt symptomatic relief. Additionally, chronic animal studies demonstrated silica urolithiasis at high doses, raising long-term safety concerns that further limited its approval for unsupervised consumer use. ### What is the acid-neutralizing capacity of magnesium trisilicate? According to USP data, magnesium trisilicate has a theoretical acid-neutralizing capacity of approximately 12–17 mEq per gram when suspended in water. While this value is comparatively high among antacid compounds, the slow rate of reaction with hydrochloric acid means the full neutralizing potential is not realized quickly enough for effective acute symptom relief. ### Can magnesium trisilicate interact with antibiotics or other medications? Yes, magnesium trisilicate significantly reduces the oral bioavailability of tetracycline-class antibiotics and fluoroquinolones by forming insoluble chelate complexes in the gastrointestinal tract, potentially reducing antibiotic absorption by over 50%. It also impairs absorption of iron supplements, ketoconazole, and digoxin; patients should separate administration of these drugs by at least 2 hours before or 4 hours after magnesium trisilicate ingestion. ### What are the risks of taking magnesium trisilicate long-term? Long-term or high-dose use of magnesium trisilicate carries a risk of silica urolithiasis, where silicon dioxide deposits accumulate in the urinary tract and form kidney stones, as demonstrated in animal models. Patients with chronic kidney disease face additional risk of hypermagnesemia because impaired renal function limits magnesium excretion, potentially causing neuromuscular toxicity, hypotension, and cardiac conduction abnormalities at elevated serum levels. ### What is magnesium trisilicate used for in the pharmaceutical industry beyond antacids? In pharmaceutical manufacturing, magnesium trisilicate serves as an excipient and purification agent due to its strong adsorptive properties; its colloidal silica structure binds fatty acids, colored impurities, and polar contaminants from oils and drug formulations. It is also used as a glidant and anti-caking agent in tablet manufacturing, improving powder flow characteristics during compression processes. ### How does magnesium trisilicate's crystal structure affect its ability to absorb impurities? Magnesium trisilicate has an open crystal lattice structure that enables it to adsorb fatty acids, bile acids, and other impurities through physical surface interactions rather than chemical bonding. This adsorptive property makes it useful in pharmaceutical formulations for purification purposes beyond simple acid neutralization. The porous nature of its crystal arrangement is what distinguishes it from other magnesium-based compounds with denser structures. ### Why does magnesium trisilicate react slowly with stomach acid compared to other antacids? Magnesium trisilicate's reaction time with gastric acid is considerably slower than soluble antacids like magnesium hydroxide or aluminum hydroxide, which limits its effectiveness for rapid symptom relief in acute heartburn situations. This slow kinetics is partly due to its complex silicate structure requiring gradual hydrolysis and dissociation in acidic conditions. Despite theoretical acid-neutralizing capacity of 12-17 mEq per gram, the delayed reaction time led to its removal from OTC antacid formulations in the United States. ### What is the current regulatory status of magnesium trisilicate in different countries? While magnesium trisilicate was removed from OTC antacid approval in the United States, it remains approved and used in some international pharmaceutical markets, particularly in older formulations or regions with different regulatory standards. Its status varies by country, with some nations still permitting it in prescription antacid combinations for peptic ulcer disease. The shift away from magnesium trisilicate in Western markets reflects changes in antacid preferences and safety considerations over recent decades. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*